Randomized trials analyzed as observational studies

Miguel A Hernán et al. Ann Intern Med. 2013.

. 2013 Oct 15;159(8):560-2.

doi: 10.7326/0003-4819-159-8-201310150-00709.

No abstract available

References

1. Robins JM, Hernán MA. Estimation of the causal effects of time-varying exposures. In: Fitzmaurice G, Davidian M, Verbeke G, Molenberghs G, editors. Advances in Longitudinal Data Analysis. New York: Chapman and Hall/CRC Press; 2009.
1. Lesko SM, Mitchell AA. The use of randomized controlled trials for pharmacoepidemiologic studies. In: Strom BL, Kimmel SE, Hennessy S, editors. Pharmacoepidemiology. West Sussex, England: Wiley-Blackwell; 2012.
1. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin therapy in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–33. - PubMed
1. Toh S, Hernández-Díaz S, Logan RW, et al. Estimating absolute risks in the presence of non-adherence: an application to a follow-up study with baseline randomization. Epidemiology. 2010;21:528–39. - PMC - PubMed
1. Robins JM, Greenland S. Adjusting for differential rates of PCP prophylaxis in high- versus low-dose AZT treatment arms in an AIDS randomized trial. Journal of the American Statistical Association. 1994;89:737–749.